Global Cord Blood Corporation (CO) Misses Q4 EPS by 2c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Total darkness, then sunset as full eclipse wows spectators in Spain
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2020
June 29, 2020 4:16 PM EDTAdded 18,488 New Subscribers in 4Q204Q20 Revenues Increased by 19.2% YoY to RMB299.9 Million ($42.4 Million)4Q20 Operating Income Increased by 68.1% YoY to RMB149.3 Million ($21.1 Million)Non-GAAP Operating Income Up 58.7% YoY to RMB161.7 Million ($22.8 Million)Conference Call to be Held on June 30, 2020 at 8:00 a.m. ET
HONG KONG, June 29, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic... More
